StockWatch
·

Piramal Pharma Ltd Q4 FY25 Results

PPLPHARMAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue2.8K24.9%
Total Income2.8K26.2%
Expenditure2.5K17.2%
PBT256.58415.7%
Net Profit153.504071.2%
OPM20.37%32.28pp
NPM5.49%6.09pp
EPS1.163766.7%
View full financials

Informational and educational content only. Not investment advice.